Taurine antagonizes the alpha-adrenergic-positive inotropic effect of phenylephrine. 1983

F Franconi, and I Stendardi, and P Failli, and G Antonini, and F Bennardini, and R Matucci, and S Manzini, and A Giotti

UI MeSH Term Description Entries
D008297 Male Males
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011941 Receptors, Adrenergic Cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. The two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. Adrenergic receptors may also be classified according to the subtypes of G-proteins with which they bind; this scheme does not respect the alpha-beta distinction. Adrenergic Receptors,Adrenoceptor,Adrenoceptors,Norepinephrine Receptor,Receptors, Epinephrine,Receptors, Norepinephrine,Adrenergic Receptor,Epinephrine Receptors,Norepinephrine Receptors,Receptor, Adrenergic,Receptor, Norepinephrine
D011942 Receptors, Adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation. Adrenergic alpha-Receptor,Adrenergic alpha-Receptors,Receptors, alpha-Adrenergic,alpha-Adrenergic Receptor,alpha-Adrenergic Receptors,Receptor, Adrenergic, alpha,Adrenergic alpha Receptor,Adrenergic alpha Receptors,Receptor, alpha-Adrenergic,Receptors, alpha Adrenergic,alpha Adrenergic Receptor,alpha Adrenergic Receptors,alpha-Receptor, Adrenergic,alpha-Receptors, Adrenergic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013268 Stimulation, Chemical The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Stimulation,Chemical Stimulations,Stimulations, Chemical

Related Publications

F Franconi, and I Stendardi, and P Failli, and G Antonini, and F Bennardini, and R Matucci, and S Manzini, and A Giotti
July 1967, Life sciences,
F Franconi, and I Stendardi, and P Failli, and G Antonini, and F Bennardini, and R Matucci, and S Manzini, and A Giotti
October 1989, Journal of molecular and cellular cardiology,
F Franconi, and I Stendardi, and P Failli, and G Antonini, and F Bennardini, and R Matucci, and S Manzini, and A Giotti
April 1984, European journal of pharmacology,
F Franconi, and I Stendardi, and P Failli, and G Antonini, and F Bennardini, and R Matucci, and S Manzini, and A Giotti
April 1977, Canadian journal of physiology and pharmacology,
F Franconi, and I Stendardi, and P Failli, and G Antonini, and F Bennardini, and R Matucci, and S Manzini, and A Giotti
February 1997, European journal of pharmacology,
F Franconi, and I Stendardi, and P Failli, and G Antonini, and F Bennardini, and R Matucci, and S Manzini, and A Giotti
January 1990, British journal of clinical pharmacology,
F Franconi, and I Stendardi, and P Failli, and G Antonini, and F Bennardini, and R Matucci, and S Manzini, and A Giotti
May 1975, British journal of pharmacology,
F Franconi, and I Stendardi, and P Failli, and G Antonini, and F Bennardini, and R Matucci, and S Manzini, and A Giotti
November 1980, Experientia,
F Franconi, and I Stendardi, and P Failli, and G Antonini, and F Bennardini, and R Matucci, and S Manzini, and A Giotti
September 1987, Japanese journal of pharmacology,
F Franconi, and I Stendardi, and P Failli, and G Antonini, and F Bennardini, and R Matucci, and S Manzini, and A Giotti
March 1982, Naunyn-Schmiedeberg's archives of pharmacology,
Copied contents to your clipboard!